June 2nd 2017The power of lobbies
A combined effect of EU-level policies and corporate lobbying is creating a pro-privatisation environment for healthcare provision in Europe. Our new research explores the EU policy areas – and the role of corporate lobbying – that encourages more privatised models of healthcare: marketisation, trade, public private partnerships, and economic governance.
Major news on the glyphosate front: the first ever independent analysis of the complete confidential data set sent by industry to the EU for the re-licensing of glyphosate, enabled by an exceptional disclosure, shows possible serious omissions in EFSA and ECHA's safety assessment. It is high time the complete data set is published in full to enable full scrutiny by the scientific community.